Itzhak Goldberg - Dec 1, 2021 Form 4 Insider Report for Angion Biomedica Corp. (ELTX)

Role
Executive Chairman and Chief Scientific Officer, Director
Signature
/s/ Jennifer J. Rhodes, as attorney-in fact for Itzhak Goldberg
Stock symbol
ELTX
Transactions as of
Dec 1, 2021
Transactions value $
-$410,211
Form type
4
Date filed
12/3/2021, 05:03 PM
Previous filing
Nov 17, 2021
Next filing
Dec 7, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELTX Common Stock Sale -$138K -38.9K -2.08% $3.54 1.83M Dec 1, 2021 Direct F1, F2
transaction ELTX Common Stock Sale -$136K -38.8K -2.12% $3.51 1.79M Dec 2, 2021 Direct F1, F3
transaction ELTX Common Stock Sale -$136K -40.2K -2.24% $3.39 1.75M Dec 3, 2021 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2021 by the Reporting Person
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.31 to $3.79 inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.36 to $3.64 inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.29 to $3.50 inclusive.

Remarks:

Executive Chairman and Chief Scientific Officer